Color orado A o ALTO P Project Data Training Data Training - - PowerPoint PPT Presentation

▶
color orado a o alto p project
SMART_READER_LITE
LIVE PREVIEW

Color orado A o ALTO P Project Data Training Data Training - - PowerPoint PPT Presentation

Oct 22, 2023 34 likes •204 views

Color orado A o ALTO P Project Data Training Data Training Objectives Understand the alarming statistics/background Discuss the population of interest and timeframe Review naming report conventions; drugs monitored in the program;

slide-1
SLIDE 1

Data Training

Color

  • rado A
  • ALTO P

Project

slide-2
SLIDE 2

Data Training Objectives

  • Understand the alarming statistics/background
  • Discuss the population of interest and timeframe
  • Review naming report conventions; drugs monitored in the

program; final measures and what reports to submit to CHA

  • Review the auditing report
  • Discuss the lessons learned from the Opioid Safety Pilot
  • Questions
slide-3
SLIDE 3

Alarming Statistics

  • Pain is the most common reason for visit

to the Emergency Department (ED).

  • Colorado is at the center of the U.S.
  • pioid epidemic with the 12th highest

rate of misuse and abuse of prescription

  • pioids across all 50 states.
  • Four out of 10 Colorado adults admit to

misuse of prescription medication: primarily pain killers.

  • Overdoses: Two of every three from pharmaceuticals, compared to
  • ne of three from heroin.
  • EDs are in a strong position to reduce opioid use in a population at

high risk for misuse and abuse through alternative pain management strategies.

slide-4
SLIDE 4

Background

slide-5
SLIDE 5

Background

  • The United States has 10 percent of the world’s population,

yet consumes more than 80 percent of the world’s opioids.

  • In 2010, opioid consumption was 710 Morphine milligram

equivalents (MME) per person in the U.S. on a yearly basis.

slide-6
SLIDE 6

Background

slide-7
SLIDE 7

Colorado ALTO Project

slide-8
SLIDE 8

Population of Interest and Timeframe

  • Population of Interest
  • Emergency department patients receiving and opioid or an alternative to
  • pioid (ALTO) administration
  • Adults age 18 years old to 100 years old
  • Timeframe
  • Baseline data: Three months of data collection prior to launch
  • Example: Project launch Aug 2018, Baseline May – July 2018
  • Project data: Nine months of data collection
  • Data submissions must start on the first of selected month
  • Must contain full month of data
slide-9
SLIDE 9

Naming Report Conventions

  • HospID
  • CHA assigned HospID attached in Data Manual
  • ADM or EHR
  • ADM = Administrative Data
  • EHR = Electronic Health Record
  • YYYYMM
  • Most recent month of records
  • Baseline
  • Place in name if data is baseline
  • If not baseline then omit
  • V2, V3, etc.
  • Place in name if resubmitting data to Sharepoint
  • Examples:
  • 999_ADM_encounters_201805_baseline.xls
  • 999_EHR_201802.xls
  • 999_EHR_201802_V2.xls
slide-10
SLIDE 10

Drugs Monitored

Opiates

  • Buprenorphine
  • Codeine
  • Fentanyl nasal spray
  • Hydrocodone
  • Hydromorphone
  • Meperidine
  • Methadone
  • Morphine
  • Oxycodone
  • Tramadol

ALTOs

  • Ketamine
  • Lidocaine nasal spray
  • Lidocaine IV
  • Lidocaine patch
  • Lidocaine topical
  • Toradol (ketorolac

tromethamine)

  • Haldol (haloperidol)
  • Acetaminophen
  • Ibuprofen
  • Bentyl (dicyclomine)
slide-11
SLIDE 11

Final Measures

Tier 1

  • Opioids Administered per 1000 ED

Visits

  • ALTOs Administered per 1000 ED Visits
  • Morphine Equivalent Units (MEU) per

1000 ED Visits

Tier 2

  • Opioid/ALTO Prescription Trends

Physicians

  • ALTO: Opioids Prescription Ratio
slide-12
SLIDE 12

Reports to Submit

ADM - Total ED Visits per Month

  • Filename: 999_ADM_encounters_201803.xls

EHR – Medication Administration

  • Filename: 999_EHR_201601.xls

Hospital_ID Data_Start_Date Data_End_Date Total_ED_Visits 999 01/01/2016 01/31/2016 796 999 02/01/2016 02/28/2016 800 999 03/01/2016 03/31/2016 808 HospID PAN MRN Admin Date Med Route Dose Unit Prov NPI 999 ABCDEF A1B2C3 01/01/2016 Dilaudid Hydromorphone IV Intravenous .5 15 MG ML 00000 999 123456 789002 01/01/2016 Fentanyl Intravenous 35 MCG 00000

slide-13
SLIDE 13

Auditing Report

HospID PAN MRN Admin Date Med Route Dose Unit Prov NPI 999 ABCDEF A1B2C3 01/01/2016 Dilaudid Hydromorphone IV Intravenous .5 15 MG ML 00000 999 123456 789002 01/01/2016 Fentanyl IV 35 MCG 00000 HospID PAN MRN Admin Date Med Route Dose Unit Prov NPI 999 ABCDEF A1B2C3 01/01/2016 Hydromorphone IV .5 mg 00000 999 ABCDEF A1B2C3 01/01/2016 Hydromorphone IV .5 mg 00000 999 123456 789002 01/01/2016 Fentanyl IV 35 MCG 00000

slide-14
SLIDE 14

Lessons Learned: Opioid Safety Pilot

  • Understanding your Hospitals EHR ecosystem
  • Hospital Wide EHR vs ED EHR
  • Building custom reports
  • EHR assistance or Manual?
  • Identifying your role
  • Report Writer: Auditing/Managing the data report
  • Data Report Creator: Creating/running data report
  • Clinical Data Reviewer: Auditing data for correctness
  • Communication/Team effort
slide-15
SLIDE 15

Partners

slide-16
SLIDE 16

Questions?

Resources www.cha.com/opioid Contact Information

Dominick Kuljis, MPH CHA Health Care Research Analyst dominick.kuljis@cha.com 720.330.6057

slide-17
SLIDE 17

You save e lives es ev every day … … Thank y you.